ASIA unversity:Item 310904400/16405
English  |  正體中文  |  简体中文  |  Items with full text/Total items : 90453/105671 (86%)
Visitors : 16036443      Online Users : 107
RC Version 6.0 © Powered By DSPACE, MIT. Enhanced by NTU Library IR team.
Scope Tips:
  • please add "double quotation mark" for query phrases to get precise results
  • please goto advance search for comprehansive author search
  • Adv. Search
    HomeLoginUploadHelpAboutAdminister Goto mobile version

    Please use this identifier to cite or link to this item:

    Title: Benzyl isothiocyanate (BITC) inhibits migration and invasion of human colon cancer HT29 cells by inhibiting matrix metalloproteinase-2/-9 and urokinase plasminogen (uPA) through PKC and MAPK signaling pathway
    Authors: 賴光啟;LAI, KUANG-CHI;黃安正;HUANG, AN-CHENG;徐素琴;HSU, SHU-CHUN;郭昭麟;KUO, CHAO-LIN;楊家欣;YANG, JAI-SING;吳莘華;SHIN-HWAR, WU;鍾景光;Chung, Jing-Gung
    Contributors: 生物科技學系
    Keywords: BITC;migration;invasion;MMP2;MMP9;human colon cancer HT29 cells
    Date: 2010-03
    Issue Date: 2012-11-23 17:12:38 (UTC+8)
    Abstract: Benzyl isothiocyanate (BITC), a component of dietary cruciferous vegetables, has antioxidant and
    anticancer properties. In this study, we show for the first time the antimetastatic effects of BITC in
    human colon cancer HT29 cells. BITC had an inhibitory effect on cell migration and invasion. Protein
    levels of matrix metalloproteinase-2 (MMP-2), matrix metalloproteinase-9 (MMP-9), and urokinaseplasminogen activator (u-PA) were reduced by BITC in a concentration-dependent manner. BITC
    also exerted an inhibitory effect on phosphorylation of c-Jun N-terminal kinase 1 and 2 (JNK1/2),
    extracellular signal-regulated kinases 1 and 2 (ERK1/2), phosphatidylinositol 3-kinase (PI3K) and
    protein kinase C (PKC) that are upstream of nuclear factor kappa B (NF-κB). BITC inhibited DNA
    binding activity of NF-κB. Moreover, BITC decreased the levels of c-Fos, c-Jun, Ras, FAK, PI3K and
    GRB2 in HT29 cells. Reductions in the enzyme activity, protein and mRNA (mRNA) levels of MMP-2
    were observed in BITC-treated HT29 cells. BITC also inhibited mRNA levels of MMP-2, -7, and -9 in
    HT29 cells. Results from zymography showed that BITC treatment decreased MMP-2 expression in
    a concentration-dependent manner. BITC inhibited PKCδ activity in HT29 cells. Furthermore,
    inhibitors specific for JNK (SP600125) reduced expression of MMP-2, MMP-9, and u-PA. These
    results demonstrated that BITC could alter HT29 cell metastasis by reduction of MMP-2, MMP-9,
    and u-PA expression through the suppression of a PKC, MAPK signaling pathway and inhibition of
    NF-κB levels. These findings suggest that BITC has potential as an antimetastatic agent.
    Appears in Collections:[Department of Biotechnology] Journal Article

    Files in This Item:

    File Description SizeFormat

    All items in ASIAIR are protected by copyright, with all rights reserved.

    DSpace Software Copyright © 2002-2004  MIT &  Hewlett-Packard  /   Enhanced by   NTU Library IR team Copyright ©   - Feedback